We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Wearable Ultrasound Platform Paves Way for 24/7 Blood Pressure Monitoring On the Wrist

By MedImaging International staff writers
Posted on 26 Mar 2024
Print article
Image: Novosound has secured a patent for its wireless wearable ultrasound imaging platform (Photo courtesy of Novosound)
Image: Novosound has secured a patent for its wireless wearable ultrasound imaging platform (Photo courtesy of Novosound)

An innovative wearable ultrasound technology addresses the limitations of traditional ultrasound and has paved the way for cutting-edge wearable healthcare technology devices that could transform health monitoring and diagnostics.

Novosound (Glasgow, Scotland), a company specializing in high-resolution, flexible ultrasound transducers for wearable applications, has successfully scaled down traditional ultrasound components and integrated them into user-friendly, wearable formats. This breakthrough enables real-time monitoring of various health conditions while eliminating the need for bulky, stationary equipment. This innovative approach enhances patient comfort as well as paves the way for new possibilities in continuous health monitoring and preventive care. Novosound’s wearable ultrasound devices offer continuous, non-invasive monitoring while seamlessly integrating into the daily lives of patients. Designed for comfort and efficiency, these devices are revolutionizing the way clinicians approach health, from cardiovascular monitoring to obstetric care and beyond.

Novosound’s novel, thin-film, ultrasound technology is being used as a wearable ultrasound sensor for healthcare, including an intelligent, autonomous bladder monitoring device and wearable lung device for remote monitoring and future diagnosis. Their lightweight and discrete nature makes Novosound’s sensors ideal for integration into wearable devices. Novosound’s ultrasound technology enables continuous and real-time monitoring of blood pressure. This can especially benefit individuals with conditions such as hypertension by providing a constant stream of data that can be utilized to identify patterns and trends in blood pressure fluctuations. In contrast to traditional methods involving cuffs and other restrictive devices, Novosound’s wireless wearable ultrasound technology does away with the need for such accessories. This not only makes the monitoring process more comfortable for users but also increases their adherence to long-term monitoring. Novosound has now secured a patent for its ultrasonic instrumentation system and recently launched its related Slanj platform targeted at the medical and wearable device sectors.

“I’m really proud that Novosound has obtained the first patent for a wearable ultrasound system,” said Dr. Dave Hughes, CEO and Co-founder of Novosound. “This allows us to integrate and license the technology with smartwatch partners, looking deeper into the body and enhancing the measurements their optical and electrical sensors provide, opening up the holy grail of 24/7 blood pressure monitoring on the wrist.”

 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Ergonomic Advantage (EA) Line
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Color Doppler Ultrasound System
KC20

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.